Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04581382
Brief Title: Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

First Submitted : September 18, 2020
First Submitted that Met QC Criteria : October 5, 2020
First Posted : October 9, 2020

Last Update Submitted that Met QC Criteria : June 15, 2021
Last Update Posted : June 21, 2021